NDC 64896-663

RYTARY

Levodopa And Carbidopa

RYTARY is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Levodopa; Carbidopa.

Product ID64896-663_1e73c6f1-dbdf-48e6-82ad-8c65a55efcd0
NDC64896-663
Product TypeHuman Prescription Drug
Proprietary NameRYTARY
Generic NameLevodopa And Carbidopa
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2015-01-12
Marketing CategoryNDA / NDA
Application NumberNDA203312
Labeler NameAmneal Pharmaceuticals LLC
Substance NameLEVODOPA; CARBIDOPA
Active Ingredient Strength195 mg/1; mg/1
Pharm ClassesAromatic Amino Acid [EPC],Amino Acids, Aromatic [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 64896-663-01

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-663-01)
Marketing Start Date2015-01-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64896-663-01 [64896066301]

RYTARY CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA203312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-01-12

NDC 64896-663-43 [64896066343]

RYTARY CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA203312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-01-12

NDC 64896-663-99 [64896066399]

RYTARY CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA203312
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-01-12

NDC 64896-663-09 [64896066309]

RYTARY CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA203312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-01-12

Drug Details

Active Ingredients

IngredientStrength
LEVODOPA195 mg/1

OpenFDA Data

SPL SET ID:6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1600773
  • 1600776
  • 1600774
  • 1600775
  • 1600916
  • 1600917
  • 1600914
  • 1600915
  • UPC Code
  • 0364896662019
  • 0364896664013
  • 0364896661012
  • 0364896663016
  • Pharmacological Class

    • Aromatic Amino Acid [EPC]
    • Amino Acids
    • Aromatic [CS]

    Medicade Reported Pricing

    64896066343 RYTARY ER 48.75 MG-195 MG CAP

    Pricing Unit: EA | Drug Type:

    64896066301 RYTARY ER 48.75 MG-195 MG CAP

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "RYTARY" or generic name "Levodopa And Carbidopa"

    NDCBrand NameGeneric Name
    64896-661RYTARYLevodopa and Carbidopa
    64896-662RYTARYLevodopa and Carbidopa
    64896-663RYTARYLevodopa and Carbidopa
    64896-664RYTARYLevodopa and Carbidopa

    Trademark Results [RYTARY]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RYTARY
    RYTARY
    88751361 not registered Live/Pending
    Amneal Pharmaceuticals LLC
    2020-01-08
    RYTARY
    RYTARY
    85931781 4782446 Live/Registered
    Impax Laboratories, Inc.
    2013-05-14
    RYTARY
    RYTARY
    85586918 4724116 Live/Registered
    IMPAX LABORATORIES, LLC
    2012-04-02

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.